Share
Journal Information
Issue
Vol. 43. Issue S3.Pages Z1-Z6 (November 2021)
Speaker presentations
PREDICTORS OF OUTCOME AND SURVIVAL IN PROSTATE CANCER – DATA FROM TERTIARY CARE UROLOGY INSTITUTE IN PAKISTAN
Syed Najeeb Niamatullah
Hematol Transfus Cell Ther. 2021;43 Supl 3:S1-S2
Open access
Speaker presentations
GENERIC IMATINIB VS GLEEVEC
Katia Borgia Barbosa Pagnano
Hematol Transfus Cell Ther. 2021;43 Supl 3:S2-S3
Open access
REVIEW OF NEW INDICATIONS – JOURNAL OF CLINICAL APHERESIS PERSPECTIVE
Huy Pham
Hematol Transfus Cell Ther. 2021;43 Supl 3:S3
Open access
HOW I TREAT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS?
María-Victoria Mateos
Hematol Transfus Cell Ther. 2021;43 Supl 3:S3
Open access
TREATMENT OF RELAPSED, REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
Ebru Pekgüç, Burhan Ferhanoğlu
Hematol Transfus Cell Ther. 2021;43 Supl 3:S4
Open access
HAPLOIDENTICAL VERSUS UNRELATED ALLOGENEIC STEM CELL TRANSPLANTATION FOR ADULTS WITH ACUTE LEUKEMIA
Arnon Nagler
Hematol Transfus Cell Ther. 2021;43 Supl 3:S4-S5
Open access
EVOLUTION OF THE PLEURAL SECRETOME ASSOCIATED WITH PLEURAL METASTASIS
Albert D. Donnenberg, James D. Luketich, Ibrahim Sultan, Vera S. Donnenberg
Hematol Transfus Cell Ther. 2021;43 Supl 3:S6
Open access
INTRAPLEURAL THERAPY TO DRIVE SYSTEMIC ANTI-TUMOR IMMUNITY
Vera S. Donnenberg, James D. Luketich, David L. Bartlett, Albert D. Donnenberg
Hematol Transfus Cell Ther. 2021;43 Supl 3:S6-S7
Open access
TARGETED THERAPY IN AML TREATMENT
Giovanni Martinelli
Hematol Transfus Cell Ther. 2021;43 Supl 3:S7-S8
Open access
HAEMOPHILIA AND NURSING CARE
Marcela Ganzella
Hematol Transfus Cell Ther. 2021;43 Supl 3:S8
Open access
THE APPROACH AND DIAGNOSIS OF COOMBS NEGATIVE HEMOLYTIC ANEMIAS
Achille Iolascon
Hematol Transfus Cell Ther. 2021;43 Supl 3:S8
Open access
Pediatric presentations
NEW ADVANCES IN PEDIATRIC ACUTE MYELOID LEUKEMIA
Özlem Tüfekçi
Hematol Transfus Cell Ther. 2021;43 Supl 3:S9-S10
Open access
MEDICAL TREATMENT IN HODGKIN LYMPHOMA
Nilgun Kurucu
Hematol Transfus Cell Ther. 2021;43 Supl 3:S10
Open access
LATE EFFECTS OF CHILDHOOD CANCER: THE FOUNDATION FOR RISK-STRATIFIED PEDIATRIC CANCER CARE LONG TERM
Melissa M. Hudson
Hematol Transfus Cell Ther. 2021;43 Supl 3:S11-S12
Open access
UPDATE ON FERTILITY PRESERVATION
Murat Sönmezer
Hematol Transfus Cell Ther. 2021;43 Supl 3:S12
Open access
PRINCIPLES OF TRANSFUSION IN CHILDREN WITH CANCER
Dilek Gürlek Gökçebay
Hematol Transfus Cell Ther. 2021;43 Supl 3:S12-S13
Open access
AN APPROACH TO PAIN IN CHILDREN WITH CANCER
Yavuz Akçaboy
Hematol Transfus Cell Ther. 2021;43 Supl 3:S13
Open access
MEDICAL TREATMENT IN EWING SARCOMA
Roberto Luksch
Hematol Transfus Cell Ther. 2021;43 Supl 3:S13-S14
Open access
Oral presentations
THE IMPACT OF TYROSINE KINASE INHIBITORS ON FATHERHOOD IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA, A SINGLE INSTITUTION EXPERIENCE
Mohammad Abu-Tineh, Awni Alshurafa, Elrazi Awadelkarim Hamid Ali, Ashraf Omer Elamin Ahmed, Khalid Mohamed Ibrahim Alhaj ALbsheer, Yousef Hailan, Waail Rozi, Abdulqader Nashwan, Mohamed Yassin
Hematol Transfus Cell Ther. 2021;43 Supl 3:S15
Open access
PROGNOSIS FACTORS IN AGGRESSIVE NON-HODGKIN LYMPHOMAS WITH PRIMARY INVOLVEMENT OF THE SPLEEN
Larisa Musteata, Ion Corcimaru, Vasile Musteata
Hematol Transfus Cell Ther. 2021;43 Supl 3:S15-S16
Open access
CLINICAL CHARACTERISTICS, AND SURVIVAL RATE OF ELDERLY PATIENTS WITH NON-HODGKIN'S LYMPHOMAS WITH PRIMARY INVOLVEMENT OF PERIPHERAL LYMPH NODES
Tomacinschii Victor, Buruiana Sanda, Robu Maria
Hematol Transfus Cell Ther. 2021;43 Supl 3:S16
Open access
UPSHOTS IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: ANALYSIS OF T-CELL BRAZIL PROJECT
Carlos CHIATTONE, Eliana MIRANDA, Marcia DELAMAIN, Juliana PEREIRA, Natalia ZING, Danielle FARIAS, Guilherme DUFFLES, Marcelo BELLESSO, ... Carmino SOUZA
Hematol Transfus Cell Ther. 2021;43 Supl 3:S16-S17
Open access
IMPACT OF BONE MARROW FIBROSIS IN MYELOMA PATIENTS UNDERGONE AUTOLOGOUS STEM CELL TRANSPLANTATION
Senem Maral, Murat Albayrak, Gülten Korkmaz, Simten Dagdas, Berna Afacan Öztürk, Aynur Albayrak, Ünsal Han, Merih Reis Aras, Gülsüm Özet
Hematol Transfus Cell Ther. 2021;43 Supl 3:S17
Open access
INVESTIGATION OF THE QUALIFICATION OF RADIOLOGICAL TECHNIQUES TO DETECT OSTEOLYTIC LESIONS, FRACTURES, AND OSTEOPOROSIS IN MULTIPLE MYELOMA PATIENTS
Atakan Turgutkaya, İrfan Yavaşoğlu, Tuğba Şahin, Ali Zahit Bolaman
Hematol Transfus Cell Ther. 2021;43 Supl 3:S17-S18
Open access
ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: IKEMA SUBGROUP ANALYSIS
Mehmut TURGUT, Roman HAJEK, Tomas JELÍNEK, Philippe MOREAU, Thomas MARTIN, Ludek POUR, Gabor MIKALA, Argiris SYMEONIDIS, ... Ivan SPICKA
Hematol Transfus Cell Ther. 2021;43 Supl 3:S18
Open access
OUTCOME OF SPLENECTOMY IN THE TREATMENT OF ITP – ONE CENTER EXPERIENCE
Weronika Lebowa, Joanna Zdziarska, Tomasz Sacha
Hematol Transfus Cell Ther. 2021;43 Supl 3:S18-S19
Open access
DIRECT ORAL ANTICOAGULANTS IN SICKLE CELL DISEASE, WHERE WE STAND AND WHERE WE ARE HEADING: A SYSTEMATIC REVIEW
Waail Rozi, Elrazi Ali, Alaa Rahhal, Abdulrahman Al-Mashdali, Yousef Hailan, Mohamed Yassin
Hematol Transfus Cell Ther. 2021;43 Supl 3:S19
Open access
ANTI-GLYCAN ANTIBODIES IN THE DIAGNOSIS OF GASTRIC CANCER
Nadezhda Shilova, Maxim Nikulin, Svetlana Polyakova, Alexander Lipatnikov, Maxim Navakouski, Nicolai Tupitsyn, Nicolai Bovin
Hematol Transfus Cell Ther. 2021;43 Supl 3:S19
Open access
THE IMPACT OF HEMATOLOGICAL PARAMETERS ON SURVIVAL FOR PATIENTS WITH COVID-19
Fatma YILMAZ, Murat ALBAYRAK, Abdülkerim YILDIZ, Hacer Berna AFACAN ÖZTÜRK, Senem MARAL, Ümit Yavuz MALKAN, Pınar AKYOL, Merih REİS ARAS, ... Mesut TIĞLIOĞLU
Hematol Transfus Cell Ther. 2021;43 Supl 3:S19-S20
Open access
AN UNUSUAL SURVIVING HISTORY: MULTISYSTEM INVOLVEMENT UNTIL ADULT LIFE WITH NIEMANN PICK TYPE B
Özden ÖZLÜK, Metban GÜZEL MASTANZADE, Beyza ŞEN OLUK, Sevgi KALAYOĞLU BEŞIŞIK, Bezirgen BALLYYEV
Hematol Transfus Cell Ther. 2021;43 Supl 3:S20
Open access
LEWIS C IN BREAST CANCER PROGRESSION
Нина Гадецкая
Hematol Transfus Cell Ther. 2021;43 Supl 3:S20-S21
Open access
B1-CELLS OF INNATE IMMUNITY IN THE BONE MARROW IN BREAST CANCER PATIENTS: IDENTIFICATION AND THEIR RELATIONSHIP WITH CLINICAL AND MORPHOLOGICAL PARAMETERS
Svetlana Chulkova, Nikolai Tupitsyn
Hematol Transfus Cell Ther. 2021;43 Supl 3:S21
Open access
COMPARISON OF INDIVIDUAL PHARMACOKINETIC DOSING TOOLS IN PATIENTS WITH HEMOPHILIA A
Can Alp GENÇ, Dilek GURLEK GOKCEBAY, Vildan KOSAN CULHA, Yasin KOKSAL, Zühre Kaya, Namık Yasar Ozbek
Hematol Transfus Cell Ther. 2021;43 Supl 3:S21-S22
Open access
IMMUNE THROMBOCYTOPENIA PURPURA FLARE POST SARS-COV-2 VACCINATION
Elrazi Ali, Qusai Maharmeh, Waail Rozi, Mohamed Yassin
Hematol Transfus Cell Ther. 2021;43 Supl 3:S22
Open access
THE OUTCOME OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOOD AND THE RISK FACTORS FOR CHRONICITY
Barış YILMAZ, Ahmet KOÇ, Ömer DOĞRU, Burcu TUFAN TAŞ, Rabia Emel ŞENAY, Nurşah EKER, Ayşe Gülnur TOKUÇ
Hematol Transfus Cell Ther. 2021;43 Supl 3:S22
Open access
CLINICAL AND LABORATORY EVALUATION OF OUR PATIENTS WITH HEREDITARY SPHEROCYTOSIS
Senanur Şanlı Çelik, Zeynep Yıldız Yıldırmak, Dildar Bahar Genç
Hematol Transfus Cell Ther. 2021;43 Supl 3:S22-S23
Open access
ASSESSMENT OF THE NUTRITIONAL STATUS, BONE MINERALIZATION AND ANTHROPOMETRICS OF CHILDREN WITH THALASSEMIA MAJOR
Serap Cevher Bulğurcu, Aylin Canbolat Ayhan, Hamdi Emeksiz, Fahri Ovalı
Hematol Transfus Cell Ther. 2021;43 Supl 3:S23
Open access
ANEMIA AND DIETARY BEHAVIORS AMONG YOUNG ADULTS IN RIYADH, SAUDI ARABIA
Samha Alayoubi, Ghada ELGohary, Fakhr Alayoubi
Hematol Transfus Cell Ther. 2021;43 Supl 3:S23
Open access
THE EVALUATION OF CONGENITAL NEUTROPENIA PATIENTS
Nihal Karadaş, Yeşer Yılmaz, Defne Karalar, Deniz Yılmaz Karapınar
Hematol Transfus Cell Ther. 2021;43 Supl 3:S23-S24
Open access
MANAGEMENT AND OUTCOMES OF NEUTROPENIA IN PREVIOUSLY HEALTHY CHILDREN
Hatice Mine Cakmak, Omer Kartal
Hematol Transfus Cell Ther. 2021;43 Supl 3:S24
Open access
POST-TREATMENT NUTRITIONAL STATUS OF CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
Akbar Akbarov, Aylin Canbolat Ayhan, Hamdi Emeksiz, Fahri Ovalı
Hematol Transfus Cell Ther. 2021;43 Supl 3:S24-S25
Open access
ACUTE MEGACARYOBLASTIC LEUKEMIA IN CHILDREN: DIAGNOSTICS AND MRD MONITORING
Aleksandra Palladina, Natalya Kupryshina, Aleksander Popa, Nikolai Tupitsyn
Hematol Transfus Cell Ther. 2021;43 Supl 3:S25
Open access
JUVENILE MYELOMONOCYTIC LEUKEMIA SINGLE CENTER EXPERIENCE
Yunus Murat Akcabelen, Dilek Kaçar, Ayça Koca Yozgat, Özlem Arman Bilir, Dilek Gürlek Gökçebay, Turan Bayhan, İkbal Ok Bozkaya, Namık Yaşar Özbek, Neşe Yaralı
Hematol Transfus Cell Ther. 2021;43 Supl 3:S25
Open access
MYSTERY OF iAMP
Fatma Burçin KURTİPEK, Dilek KAÇAR, Ebru TUNÇEZ, Melek IŞIK, Neşe YARALI
Hematol Transfus Cell Ther. 2021;43 Supl 3:S25-S26
Open access
DIAGNOSTIC APPLICATION AND CLINICAL SIGNIFICANCE OF FCM WELLS SCORING SYSTEM IN MYELODYSPLASTIC SYNDROMES
Reyhan Aliyeva, Agarza Aghayev, Adam Najafli, Reyhan Tagizade, Azer Kerimov
Hematol Transfus Cell Ther. 2021;43 Supl 3:S26
Open access
THE FREQUENCY OF HLA-A, B AND DRB1 ALLELES IN PATIENTS WITH BETA THALASSEMIA
Zeynep Karakas, Yasin Yilmaz, Ayse Erol, Demet Kivanc, Mediha Suleymanoglu, Hayriye Senturk Ciftci, Cigdem Cinar, Serap Karaman, ... Fatma Savran Oguz
Hematol Transfus Cell Ther. 2021;43 Supl 3:S26-S27
Open access
EVALUATION OF THE RELATIONSHIP OF ABO BLOOD GROUPS WITH MIS-C
Fatma Burçin KURTİPEK, Ahmet Vedat KAVURT, Elif ÇELİKEL, Emel UYAR, Emine AZAK, Oktay PERK, Neşe Yaralı, Namık Yaşar Özbek
Hematol Transfus Cell Ther. 2021;43 Supl 3:S27-S28
Open access
EVALUATION OF APPROPRIATE USE OF PEDIATRIC FRESH FROZEN PLASMA IN A TERTIARY CARE HOSPITAL
Dilek GURLEK GOKCEBAY, Aslı TURGUTOGLU YILMAZ, Beytullah Şantaflıoğlu, İkbal Ok Bozkaya, Neşe Yaralı, Namık Yaşar Özbek
Hematol Transfus Cell Ther. 2021;43 Supl 3:S28
Open access
COMPARABLE OUTCOMES OF ALLOGENEIC PERIPHERAL BLOOD VERSUS BONE MARROW HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN
AYÇA KOCA YOZGAT, ÖZLEM ARMAN BİLİR, İKBAL OK BOZKAYA, MELTEM ÖZGÜNER, NAMIK YAŞAR ÖZBEK
Hematol Transfus Cell Ther. 2021;43 Supl 3:S28
Open access
A RARE CAUSE OF SIDEROBLASTIC ANEMIA: TRNT1 MUTATION
Fatma Tuba YILDIRIM, Elif Benderlioğlu, Dilek Kaçar, Neşe Yaralı
Hematol Transfus Cell Ther. 2021;43 Supl 3:S28-S29
Open access
BURKITT LYMPHOMA PRESENTING WITH EYE AND KIDNEY INVOLVEMENT: CASE REPORT
Aslı Turgutoğlu Yılmaz, Derya Ozyoruk, Neriman Sarı, F.Burcin Kurtipek, Arzu Erdem, Selma Cakmakci, Sonay Incesoy, Inci Ilhan Ergurhan
Hematol Transfus Cell Ther. 2021;43 Supl 3:S29
Open access
NECESSITY FOR A CUSTOMIZED NGS PANEL FOR ACCURATE DIAGNOSIS AND TARGETED THERAPIES IN PEDIATRIC GLIAL TUMORS
Ayça Erşen Danyeli, Cengiz Yakıcıer, Bahattin Tanrıkulu, Cengiz Canpolat, M. Memet Özek
Hematol Transfus Cell Ther. 2021;43 Supl 3:S29
Open access
CONSTITUTIONAL MISSMATCH DEFECT REPAIR DISORDER (CMMRD) IN PEDIATRIC HIGH GRADE GLIOMA
Bahattin Tanrıkulu, Ayça Erşen Danyeli, Cengiz Canpolat, M. Memet Özek
Hematol Transfus Cell Ther. 2021;43 Supl 3:S29-S30
Open access
IS METHYLATION STATUS SUBGROUPING REALLY A STRONG PROGNOSTIC FACTOR IN PEDIATRIC POSTERIOR FOSSA EPENDYMOMA?
Bahattin Tanrıkulu, Ayça Erşen Danyeli, Cengiz Canpolat, M. Memet Özek
Hematol Transfus Cell Ther. 2021;43 Supl 3:S30
Open access
NEUROBLASTOMA IN A CASE OF CONGENITAL ADRENAL HYPERPLASIA
Arzu Yazal Erdem, Sonay İncesoy Özdemir, Meriç Kamak Cihan, Derya Özyörük, Neriman Sarı, İnci Ergürhan İlhan
Hematol Transfus Cell Ther. 2021;43 Supl 3:S30
Open access
CAN SERUM KL-6 LEVEL BE USED AS A MARKER IN LUNG METASTASIS OF BONE SARCOMAS?
Turan BAYHAN, Neriman SARI, Selma ÇAKMAKCI, Seda ŞAHİN, Nazan ÇİLEDAĞ, İnci İLHAN
Hematol Transfus Cell Ther. 2021;43 Supl 3:S30-S31
Open access
PROLONGED COVID-19 POSITIVITY AND CHEMOTHERAPY IN A PATIENT WITH NASOPHARENGEAL CARCINOMA
Seda Şahin, Neriman Sarı, Derya Özyörük, Sonay İncesoy Özdemir, Belgin Gülhan, İnci Ergürhan İlhan
Hematol Transfus Cell Ther. 2021;43 Supl 3:S31
Open access
EVALUATION OF CLINICAL AND LABORATORY CHARACTERISTICS OF CHILDREN WITH RHABDOID TUMOR: A MULTICENTER STUDY
Firdevs AYDIN, Can ACIPAYAM, Defne AY TUNCEL, Kemal DENİZ, Süreyya Burcu GÖRKEM, Veysel GÖK, Alper ÖZCAN, Ebru YILMAZ, ... Mehmet Akif ÖZDEMİR
Hematol Transfus Cell Ther. 2021;43 Supl 3:S31
Open access
ACUTE ABDOMEN AND ITS OUTCOMES IN CHILDREN WITH ACUTE LEUKEMIA
Huseyin Avnı Solgun, Esra Arslantaş, Gülnihal Özdemir
Hematol Transfus Cell Ther. 2021;43 Supl 3:S31-S32
Open access
Poster presentations
ASPARAGINASE INDUCED SINUS VEIN THROMBOSIS IN AN ADULT YOUNG ALL PATIENT
Beyza OLUK, Özden ÖZLÜK, Murat ÖZBALAK, Simge ERDEM, Sevgi KALAYOĞLU BEŞIŞIK
Hematol Transfus Cell Ther. 2021;43 Supl 3:S33
Open access
VENETOCLAX AZACITIDINE COMBINATION THERAPY IN FIRST-LINE TREATMENT OF ACUTE MYELOID LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE
Melda Cömert, Tuba Bulduk, Bilge Uğur, Murat Yıldırım, Selim Sayın, Alparslan Merdin, Ebru Kılıç Güneş, Elifcan Aladağ Karakulak, Meltem Aylı
Hematol Transfus Cell Ther. 2021;43 Supl 3:S33-S34
Open access
A REGISTRY-BASED, OBSERVATIONAL SAFETY STUDY OF INOTUZUMAB OZOGAMICIN (INO) IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
David MARKS, Marcos DE LIMA, Partow KEBRIAEI, Francesco LANZA, Christina CHO, Sergio GIRALT, Gizelle POPRADI, Michael HEMMER, ... Wael SABER
Hematol Transfus Cell Ther. 2021;43 Supl 3:S34
Open access
ANTI-CD52 TREATMENT EXPERIENCE IN A T-CELL PROLYMPHOCYTIC LEUKEMIA PATIENT:CASE REPORT
Senem MARAL, Murat ALBAYRAK, Hacer Berna OZTURK, MerihREIS ARAS, Fatma YILMAZ, Pınar TIGLIOGLU, Mesut TIGLIOGLU, Buğra SAGLAM
Hematol Transfus Cell Ther. 2021;43 Supl 3:S34-S35
Open access
RETROSPECTIVE EVALUATION OF PATIENTS WITH ACUTE MYELOID LEUKEMIA RECEIVING VENATOCLAX-BASED TREATMENT
EMINE DURAK, MEHMET CAN UGUR, BETUL KOYUNCU, SINEM NAMDAROĞLU, OKTAY BILGIR
Hematol Transfus Cell Ther. 2021;43 Supl 3:S35
Open access
BONE MARROW NECROSIS IN ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE REPORT
Melike Nur Ünal, Demet Kiper Ünal, Tuğba Çetintepe, Betül Bolat Küçükzeybek, Şerife Solmaz, Bahriye Payzın
Hematol Transfus Cell Ther. 2021;43 Supl 3:S35
Open access
NEXT GENERATION SEQUENCING PRACTICES IN HEMATOLOGY: A RECENT EXPERIENCE OF A SINGLE CENTER
Muruvvet Seda AYDIN, Funda CERAN, Simten DAGDAS, Gulsum OZET
Hematol Transfus Cell Ther. 2021;43 Supl 3:S35-S36
Open access
INAPPROPRIATE ADH SYNDROME OCCURING DURING B-ALL TREATMENT
Merih Reis Aras, Senem Maral, Hacer Berna Afacan Ozturk, Pinar Tiglioglu, Mesut Tiglioglu, Bugra Saglam, Fatma Yilmaz, Mustafa Onder, Murat Albayrak
Hematol Transfus Cell Ther. 2021;43 Supl 3:S36
Open access
T-ACUTE MYELOID LEUKEMIA CASE THOUGHT TO BE ASSOCIATED WITH RADIOIODINE (I¹³¹) TREATMENT
Merih Reis Aras, Pinar Tiglioglu, Mesut Tiglioglu, Bugra Saglam, Fatma Yilmaz, Neslihan Olgun, Senem Maral, Hacer Berna Afacan Ozturk, Murat Albayrak
Hematol Transfus Cell Ther. 2021;43 Supl 3:S36
Open access
FLT3-ITD POSITIVITY IN AML; CASE SERIES
Kemal FİDAN
Hematol Transfus Cell Ther. 2021;43 Supl 3:S36-S37
Open access
EXPERIENCE OF GLASDEGIB IN PATIENTS WITH ELDERLY ACUTE MYELOID LEUKEMIA
Nanişe Gizem FENER, Oktay BİLGİR
Hematol Transfus Cell Ther. 2021;43 Supl 3:S37
Open access
SYNTHETIC BIOLOGY MEETS PRECISION MEDICINE: DRUG REPURPOSING FOR BLOOD CANCER PRECISION MEDICINE
Deepak Balaji Thimiri Govindaraj Thimiri Govindaraj
Hematol Transfus Cell Ther. 2021;43 Supl 3:S37-S38
Open access
AVASCULAR NECROSIS IN CHRONIC MYELOID LEUKEMIA: A REVIEW OF PATHOPHYSIOLOGY, PATIENTS’ CHARACTERISTICS, AND CLINICAL OUTCOMES
Abdulrahman Al-Mashdali, Husam Al-Dubai, Mohamed Yassin
Hematol Transfus Cell Ther. 2021;43 Supl 3:S38
Open access
SECONDARY CHRONIC MYELOID LEUKEMIA FOLLOWING RADIOACTIVE IODINE (I131)
Yousef Hailan, Mohamed Yassin
Hematol Transfus Cell Ther. 2021;43 Supl 3:S38
Open access
CONCOMITANT LATENT POLYCYTHEMIA VERA AND MGUS.
Fidan KHALILOVA, Azer KERIMOV, Zohra ALIMIRZAYEVA
Hematol Transfus Cell Ther. 2021;43 Supl 3:S38-S39
Open access
THE OUTCOME OF FATHERHOOD IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS, A SINGLE INSTITUTION EXPERIENCE
Elrazi Ali, Mohammad Abu-Tineh, Anas Babiker, Yousef Hailan, Bashir Ali, Qusai Maharmah, Zakaria Maat, Abdulatif Waggad, Mohamed Yassin
Hematol Transfus Cell Ther. 2021;43 Supl 3:S39
Open access
CONCOMITANT JAK2 AND BCR-ABL1 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA CLINICAL IMPACT AND RESPONSE TO THERAPY: A SYSTEMATIC REVIEW
Elrazi Ali, Elabbass Abdelmahmuod, Mohamed Yassin, Ashraf Ahmed, Maab Faisal
Hematol Transfus Cell Ther. 2021;43 Supl 3:S39
Open access
DOUBLE HETEROZYGOTIC FV DEFECT WITH HETEROZYGOTIC FV LEIDEN MUTATION AND FV DEFICIENCY IN THROMBOSIS
İSMAİL ALTUĞ DEMİR, HATİCE DEMET KİPER ÜNAL, ŞERİFE SOLMAZ, BAHRİYE PAYZIN, TUĞBA ÇETİNTEPE
Hematol Transfus Cell Ther. 2021;43 Supl 3:S39-S40
Open access
BLEEDING MANAGEMENT DURING DELIVERY AND POSTPARTUM PERIOD IN GLANZMANN THROMBASTHENIA: EXPERIENCES FROM TWO CASES
Özden ÖZLÜK, Mustafa Murat ÖZBALAK, Tarık Onur TİRYAKİ, Sevgi KALAYOĞLU BEŞIŞIK, Tuba SARAÇ SİVRİKOZ
Hematol Transfus Cell Ther. 2021;43 Supl 3:S40
Open access
CASE REPORT OF MARGINAL ZONE LYMPHOMA DETECTED WHILE INVESTIGATING ETIOLOGY FOR HEMOSTASIS DISORDER
Mesut Tığlıoğlu, Pınar Tığlıoğlu, Merih Reis Aras, Buğra Sağlam, Fatma Yılmaz, Senem Maral, Hacer Berna Afacan Öztürk, Murat Albayrak
Hematol Transfus Cell Ther. 2021;43 Supl 3:S40
Open access
ACQUIRED FACTOR XIII DEFICIENCY WITH RUNX1 MUTATION, A REPORT OF TWO CASES TREATED WITH FACTOR XIII CONCENTRATE
Alfadil Haroon, Ali Alahmari, Nadiah Alobaidi, Ahmed Syed Osman, Hazzaa Alzahrani
Hematol Transfus Cell Ther. 2021;43 Supl 3:S40-S41
Open access
A CASE OF MULTI REGIONAL PRIMARY MUSCLE LYMPHOMA
Beyza OLUK, Metban MASTANZADE, Nur Seda IBILI, Sevgi KALAYOĞLU BEŞIŞIK
Hematol Transfus Cell Ther. 2021;43 Supl 3:S41
Open access
A RARE CASE: POSTTRANSPLANT NK/T CELL LYMPHOMA
Pınar Tığlıoğlu, Mesut Tığlıoğlu, Merih Reis Aras, Buğra Sağlam, Fatma Yılmaz, Senem Maral, Hacer Berna Afacan Öztürk, Murat Albayrak
Hematol Transfus Cell Ther. 2021;43 Supl 3:S41
Open access
A VERY RARE CAUSE OF DIARRHEA IN A CHEMOTHERAPY-INDUCED NEUTROPENIC PATIENT: PELLAGRA
Fatma YILMAZ, Murat ALBAYRAK, Senem MARAL, Hacer Berna AFACAN ÖZTÜRK, Merih REİS ARAS, Pınar TIĞLIOĞLU, Mesut TIĞLIOĞLU, Buğra SAĞLAM
Hematol Transfus Cell Ther. 2021;43 Supl 3:S41-S42
Open access
CAVITARY PRIMARY PULMONARY LYMPHOPLASMOCYTIC LYMPHOMA COMPLICATING HENOCH–SCHÖNLEIN PURPURA
Burak GULTEKIN, Ege Sinan TORUN, Ahmet GUL, Sevgi KALAYOGLU-BESISIK
Hematol Transfus Cell Ther. 2021;43 Supl 3:S42
Open access
ANTICARDIOLIPINIC ANTIBODIES IN NON-HODGKIN LYMPHOMA
Sanda Buruiana, Minodora Mazur, Maria Robu, Victor Tomacinschii
Hematol Transfus Cell Ther. 2021;43 Supl 3:S42
Open access
A CASE OF STAGE 1E DIFFUSE LARGE B-CELL LYMPHOMA PRESENTED WITH KNEE INVOLVEMENT
Mesut Tığlıoğlu, Murat Albayrak, Pınar Tığlıoğlu, Merih Reis Aras, Buğra Sağlam, Fatma Yılmaz, Senem Maral, Hacer Berna Afacan Öztürk
Hematol Transfus Cell Ther. 2021;43 Supl 3:S42-S43
Open access
THE EFFECT OF COMORBIDITY AND BODY MASS INDEX ON SURVIVAL IN PATIENTS WITH MARGINAL ZONE LYMPHOMA
Esra TURAN ERKEK, Tuba TAHTALI
Hematol Transfus Cell Ther. 2021;43 Supl 3:S43
Open access
CASE REPORT: FOLLICULAR LYMPHOMA PRESENTED WITH CHYLOTHORAX
Senem MARAL, Murat ALBAYRAK, Berna AFACAN ÖZTÜRK, Merih REİS ARAS, Fatma YILMAZ, Pınar Tığlıoğlu, Mesut TIĞLIOĞLU, Buğra SAĞLAM
Hematol Transfus Cell Ther. 2021;43 Supl 3:S43
Open access
LENALIDOMIDE ASSOCIATED İMMUNE THROMBOCYTOPENIA: A CASE REPORT
İbrahim Halil Acar, Birol Guvenc
Hematol Transfus Cell Ther. 2021;43 Supl 3:S43-S44
Open access
CLINICAL PARAMETERS OF MULTIPLE MYELOMA PROGRESSION IN RESIDENTS OF THE GOMEL REGION OF BELARUS
Zhanna KOZICH, Victor MARTINKOV, Janna PUGACHEVA, Ludmila SMIRNOVA, Svetlana MIHNO, Anna DOMANTSEVICH
Hematol Transfus Cell Ther. 2021;43 Supl 3:S44
Open access
THE EFFECT OF BISPHOSPHONATE USE ON TREATMENT RESPONSE AND OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS
Ayşe Uysal, Mustafa Merter, Serhat Göçüncü
Hematol Transfus Cell Ther. 2021;43 Supl 3:S44-S45
Open access
INSIGHTS INTO DIAGNOSIS AND MANAGEMENT OF ADVANCED MULTIPLE MYELOMA
Vasile Musteata, Doina Ranga, Larisa Musteata, Cristina Dudnic, Nina Sghibneva-Bobeico
Hematol Transfus Cell Ther. 2021;43 Supl 3:S45
Open access
CASE REPORT: COEXISTENCE OF CELIAC DISEASE AND MULTIPLE MYELOMA
Filiz YAVASOGLU, Ciğdem OZDEMIR
Hematol Transfus Cell Ther. 2021;43 Supl 3:S45
Open access
A RARE AND COMPLEX CAUSE OF IMPOTENCE POEMS SYNDROME
Buğra Sağlam, Murat Albayrak, Mustafa Önder, Hacer Berna Afacan Öztürk, Merih Reis Aras, Pınar Tığlıoğlu, Mesut Tığlıoğlu, Fatma Yılmaz, Senem Maral
Hematol Transfus Cell Ther. 2021;43 Supl 3:S45-S46
Open access
IMMUNE THROMBOCYTOPENIA RELAPSE POST COVID-19 VACCINE IN YOUNG MALE PATIENT
Hana Qasim
Hematol Transfus Cell Ther. 2021;43 Supl 3:S46
Open access
INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Flora Peyvandi, Spero Cataland, Marie Scully, Paul Coppo, Paul Knoebl, Johanna A. Kremer Hovinga, Ara Metjian, Javier de la Rubia, ... Hilde De Winter
Hematol Transfus Cell Ther. 2021;43 Supl 3:S46-S47
Open access
EPIDEMIOLOGY, TREATMENT PATTERNS, AND CLINICAL OUTCOMES AMONG PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP) IN THE UNITED STATES: AN ELECTRONIC HEALTH RECORDS ANALYSIS
Ayoade Adeyemi, Filip Callewaert, Francesca Razakariasa, Rui de Passos Sousa
Hematol Transfus Cell Ther. 2021;43 Supl 3:S47
Open access
THE ROLE OF SUBPOPULATIONS OF MOBILIZED PERIPHERAL HEMATOPOIETIC STEM CELLS IN THE RESTORATION OF HEMATOPOIESIS DURING HIGH-DOSE CHEMOTHERAPY IN CANCER PATIENTS
Liudmila GRIVTSOVA, Nikolai TUPITSYN
Hematol Transfus Cell Ther. 2021;43 Supl 3:S47-S48
Open access
HEMATOLOGICAL FINDINGS IN COVID-19 AND INSIGHTS TO STEM CELL THERAPY
Ghada ELGohary
Hematol Transfus Cell Ther. 2021;43 Supl 3:S48
Open access
OUTCOMES OF ALLOGENEIC SC TRANSPLANT IN HEMATOLOGICAL MALIGNANCY PATIENTS USING BUSULFAN 3 (9.6 MG/KG) BASED CONDITIONING REGIMEN
Majed Altareb, Yazeed Bajuaifer, Walid Rasheed
Hematol Transfus Cell Ther. 2021;43 Supl 3:S48
Open access
A CASE OF REFRACTORY IMMUNE THROMBOCYTOPENIA APPLIED WITH AUTOLOGOUS HEMATOPOETIC STEM CELL TRANSPLANTATION
Mine KARADENIZ, Mete UCDAL, Hakan GOKER, Umit Yavuz MALKAN
Hematol Transfus Cell Ther. 2021;43 Supl 3:S48
Open access
INVESTIGATION OF DRUG-DRUG INTERACTIONS INVOLVING ANTI-INFECTIVE DRUGS IN PATIENTS UNDERWENT HEMATOPOIETIC STEM CELL TRANSPLANTATION
Ayse Gunay, Eren Demirpolat, Ali Unal
Hematol Transfus Cell Ther. 2021;43 Supl 3:S48-S49
Open access
EVALUATION OF COMMON INTERACTIONS INCLUDING ANTI-INFECTIVE DRUGS IN PATIENTS UNDERWENT AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION
Ayse Gunay, Ali Unal, Eren Demirpolat
Hematol Transfus Cell Ther. 2021;43 Supl 3:S49
Open access
THERAPEUTIC PLASMA EXCHANGE IN PATIENTS WITH NEUROLOGICAL DISEASES: A 9-YEAR, SINGLE-CENTER EXPERIENCE
Merih Reis Aras, Mehlika Panpalli Ates, Murat Albayrak, Hacer Berna Afacan Ozturk, Abdulkerim Yildiz, Fatma Yilmaz, Bugra Saglam, Selim Selcuk Comoglu
Hematol Transfus Cell Ther. 2021;43 Supl 3:S49
Open access
DOES BLOOD TYPE HAVE AN EFFECT ON THE COURSE OF COVID-19?
Fatma YILMAZ, Murat ALBAYRAK, Abdülkerim YILDIZ, Hacer Berna AFACAN ÖZTÜRK, Senem MARAL, Pınar AKYOL, Merih REİS ARAS, Buğra SAĞLAM, Mesut TIĞLIOĞLU
Hematol Transfus Cell Ther. 2021;43 Supl 3:S50
Open access
RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
Fatma YILMAZ, Murat ALBAYRAK, Merih REİS ARAS, Senem MARAL, Hacer Berna AFACAN ÖZTÜRK, Pınar TIĞLIOĞLU, Mesut TIĞLIOĞLU, Buğra SAĞLAM
Hematol Transfus Cell Ther. 2021;43 Supl 3:S50
Open access
EXTRAMEDULLARY HEMATOPOIESIS IN PATIENTS WITH TRANSFUSION DEPENDENT β-THALASSEMIA (TDT): A SYSTEMATIC REVIEW
Eihab Subahi, Fateen Ata, Hassan Choudry, Phool Iqbal, Mousa AlHiyari, Ashraf Soliman, Vincenzo De Sanctis, Mohamed Yassin
Hematol Transfus Cell Ther. 2021;43 Supl 3:S50-S51
Open access
LATE DIAGNOSIS OF CONGENITAL METHEMOGLOBINEMIA IN A 33-YEAR-OLD CYANOTIC PATIENT, CASE REPORT AND REVIEW OF LITERATURE
MAYA ALDEEB, MOHAMED YASSIN
Hematol Transfus Cell Ther. 2021;43 Supl 3:S51
Open access
A RARE ASSOCIATION IN A CASE WITH HEREDITARY SPHEROCYTOSIS: SPECTRIN BETA (SPTB) AND JAK-2 MUTATION
Fatma YILMAZ, Murat ALBAYRAK, Merih REİS ARAS, Senem MARAL, Hacer Berna AFACAN ÖZTÜRK, Pınar TIĞLIOĞLU, Mesut TIĞLIOĞLU, Buğra SAĞLAM
Hematol Transfus Cell Ther. 2021;43 Supl 3:S51
Open access
RETROSPECTIVE EVALUATION OF PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS FOLLOWED IN OUR CLINIC
Mehmet Can Ugur, Cansu Atmaca Mutlu, Sinem Namdaroglu, Füsun Gediz, Oktay Bilgir
Hematol Transfus Cell Ther. 2021;43 Supl 3:S51-S52
Open access
PILOMATRIX CARCINOMA WAS BEYOND ANY EXPECTATIONS: A CASE REPORT OF CARCINOMA CLINICIAN SHOULD BE AWARE OF IT
Abdalraouf Omar, Suad Elnnami, Ibtihaj Hassan
Hematol Transfus Cell Ther. 2021;43 Supl 3:S52
Open access
WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?
Simge ERDEM, Metban MASTANZADE, Mustafa Murat OZBALAK, Sevda SERT EKINCI, Dilek Ozden OZLUK, Tarık Onur TIRYAKI, Beyza OLUK, Ipek YONAL HINDILERDEN, ... Sevgi KALAYOGLU BESISIK
Hematol Transfus Cell Ther. 2021;43 Supl 3:S52
Open access
A RARE CAUSE OF ANEMIA IN ADULTHOOD CONGENITAL DYSERYTHROPETIC ANEMIA
Buğra Sağlam, Murat Albayrak, Hacer Berna Afacan Öztürk, Merih Reis Aras, Pınar Tığlıoğlu, Mesut Tığlıoğlu, Fatma Yılmaz, Senem Maral
Hematol Transfus Cell Ther. 2021;43 Supl 3:S52-S53
Open access
HEMATOLOGIC REFERENCE VALUES FOR HEALTHY ADULT SAUDIS
Salwa Bakr
Hematol Transfus Cell Ther. 2021;43 Supl 3:S53
Open access
A CASE REPORT WITH SEVERE CONGENITAL FACTOR XIII DEFICIENCY AND AN UNCOMPLICATED PREGNANCY AND BIRTH PROCESS
İbrahim Eker, Özge Vural, Mehmet Yılmazer, Nilgün Eroğlu, Yeter Düzenli Kar
Hematol Transfus Cell Ther. 2021;43 Supl 3:S53-S54
Open access
EVALUATION OF THE FREQUENCY OF ARTERIAL AND VENOUS THROMBOSIS AND PREDISPOSING FACTORS IN PATIENTS USING ELTROMBOPAG
Derya Deniz Kurekci, Melda Isevi, Engin Kelkitli, Mehmet Turgut
Hematol Transfus Cell Ther. 2021;43 Supl 3:S54
Open access
ETIOLOGY, TREATMENT AND FOLLOW-UP OF THROMBOSIS IN CHILDREN, ONE CENTER PROSPECTIVE TRIAL
Yunus Murat Akcabelen, Volkan Köse, Dilek Gürlek Gökçebay, Turan Bayhan, Neşe Yaralı, Namık Yaşar Özbek
Hematol Transfus Cell Ther. 2021;43 Supl 3:S54
Open access
THE EVALUATION OF HEALTHY CHILDREN WITH INCIDENTAL PROLONGATION OF PROTHROMBIN OR ACTIVATED PARTIAL THROMBOPLASTIN TESTS
Gökcen MERAL, Volkan KÖSE, Vildan ÇULHA, AYÇA KOCA YOZGATLI, NAMIK YAŞAR ÖZBEK, HÜSNİYE NEŞE YARALI
Hematol Transfus Cell Ther. 2021;43 Supl 3:S55
Open access
CHILDHOOD IMMUNE THROMBOCYTOPENIA: A MULTICENTER QUESTIONNAIRE STUDY
Ayşegül Ünüvar, Melike Sezgin Evim, Serap Karaman, Arzu Akçay, İbrahim Eker, Funda Tayfun Küpesiz, Namık Özbek, Mehmet Ertem, ... Hale Ören
Hematol Transfus Cell Ther. 2021;43 Supl 3:S55-S56
Open access
THE CLINICAL PICTURE AND LABORATORY WORK-UP OF GLANZMANN THROMBASTHENIA
Joanna Zdziarska, Teresa Iwaniec, Ewa Wypasek, Tomasz Sacha
Hematol Transfus Cell Ther. 2021;43 Supl 3:S56
Open access
THE USE OF ROMIPLOSTIM IN AN INFANT
Fatma Burçin KURTİPEK, Turan BAYHAN, Vildan ÇULHA, Neşe YARALI
Hematol Transfus Cell Ther. 2021;43 Supl 3:S56-S57
Open access
ESSENTIAL THROMBOCYTOSIS IN CHILDREN
Canan ALBAYRAK, Davut ALBAYRAK
Hematol Transfus Cell Ther. 2021;43 Supl 3:S57
Open access
GARDNER DIAMOND SYNDROME: A CASE REPORT
Elif Güney, Yasemin Ardıçoğlu Akışın, Nejat Akar
Hematol Transfus Cell Ther. 2021;43 Supl 3:S57
Open access
MYELOPEROXIDASE DEFICIENCY: SINGLE CENTER EXPERIENCE
Özlem ARMAN BİLİR, Namık Yaşar ÖZBEK
Hematol Transfus Cell Ther. 2021;43 Supl 3:S57-S58
Open access
CHARACTERISTICS AND OUTCOME OF T(8;21)-POSITIVE CHILDHOOD ACUTE MYELOID LEUKEMIA: A SINGLE INSTITUTION'S EXPERIENCE
Volkan KÖSE, Dilek KAÇAR, Özlem ARMAN BİLİR, Ayça KOCA YOZGAT, Hüsniye Neşe YARALI
Hematol Transfus Cell Ther. 2021;43 Supl 3:S58
Open access
BK-VIRUS ASSOCIATED HAEMORRHAGIC CYSTITIS CONCOMITANT WITH CHEMOTHERAPY IN AN ADOLESCENT GIRL WITH ACUTE LYMPHOBLASTIC LEUKEMIA
Aslı Turgutoğlu Yılmaz, Dilek Kacar, H. Nese Yarali, Namik Yasar Ozbek
Hematol Transfus Cell Ther. 2021;43 Supl 3:S58
Open access
A CASE OF METHOTREXATE-INDUCED PHOTOSENTIVITY REACTION
Aslı Turgutoğlu Yılmaz, Dilek Gurlek Gokcebay, Ayca Koca Yozgat, H. Nese Yarali
Hematol Transfus Cell Ther. 2021;43 Supl 3:S58-S59
Open access
UNUSUAL METABOLIC COMPLICATIONS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: HYPERCALCEMIA, HYPERAMONEMIA, LACTIC ASIDOSIS
Dilek Kaçar, Aslı Turgutoğlu Yılmaz, Ayça Koca Yozgat, Neşe Yaralı
Hematol Transfus Cell Ther. 2021;43 Supl 3:S59
Open access
CENTRAL HYPOTHROIDISM DUE TO ACUTE LYMPHOBLASTIC LEUKEMIA WITH CENTRAL NERVOUS SYSTEM INFILTRATION
Dilek Kaçar, Seda Şahin, Fatma Burçin Kurtipek, Neşe Yaralı
Hematol Transfus Cell Ther. 2021;43 Supl 3:S59
Open access
BONE AS A SITE OF EXTRAMEDULLARY DISEASE IN ACUTE LYMPHOBLASTIC LEUKEMIA
Fatma Tuba YILDIRIM, Dilek KAÇAR, Aslı TURGUTOĞLU YILMAZ, Burçin KURTİPEK, Ayça KOCA YOZGAT, Dilek GÜRLEK GÖKÇEBAY, Neşe YARALI
Hematol Transfus Cell Ther. 2021;43 Supl 3:S59
Open access
A CHALLENGE IN PEDIATRIC ACUTE LEUKEMIA TREATMENT: UNEXPECTED, PROLONGED CYTOPENIA. IS IT BE CALLLED ‘INCOMPLETE HLH’?
Ersin Toret, Sumeyye Emel Eren, Zeynep Canan Özdemir, Özcan Bör
Hematol Transfus Cell Ther. 2021;43 Supl 3:S59-S60
Open access
EVALUATION OF VACCINATION RESPONSE IN CHILDREN AFTER TREATMENT FOR ACUTE LEUKEMIA
Elif KILIC KONTE, Ayca KOCA YOZGAT, Aysun KARA UZUN, Bahar CUHACI CAKIR, Hüsniye Nese YARALI
Hematol Transfus Cell Ther. 2021;43 Supl 3:S60
Open access
PONATINIB EXPERIENCE IN A PEDIATRIC CHRONIC MYELOID LEUKEMIA PATIENT
Serap Karaman, Mustafa Bilici, Ayşegül Ünüvar, Deniz Tuğcu, Gülşah Tanyıldız, Rumeysa Tuna Deveci, Gülçin Yegen, Şifa Şahin, Zeynep Karakaş
Hematol Transfus Cell Ther. 2021;43 Supl 3:S60-S61
Open access
INVESTIGATION OF SALIVARY miR-9, miR-34a ve miR-196a LEVELS IN FANCONI ANEMIA AND ORAL SQUAMOUS CELL CARCINOMA PATIENTS
Zisan Asal Kilic, Nevin Yalman, Tulin Tiraje Celkan, Bora Basaran, Haydar Murat Yener, Selcuk Dasdemir, Mehmet Güven Günver
Hematol Transfus Cell Ther. 2021;43 Supl 3:S61
Open access
A NOVEL MISSENSE MUTATION OUTSIDE DNAJ DOMAIN OF DNAJC21 IS ASSOCIATED WITH SHWACHMAN-DIAMOND SYNDROME
Mohammad Bilal Alsavaf, Jeffrey M. Verboon, Muhammed E. Dogan, Zehra Busra Azizoglu, Fatma Zehra Okus, Alper Ozcan, Munis Dundar, Ahmet Eken, ... Ekrem Unal
Hematol Transfus Cell Ther. 2021;43 Supl 3:S61-S62
Open access
THE ROLE OF THERAPEUTIC DRUG MONITORING OF INTRAVENOUS BUSULFAN FOR PREVENTION OF SINUSOIDAL OBSTRUCTION SYNDROME IN CHILDREN
Dilek GURLEK GOKCEBAY, ÖzlemArman Bilir, Seda Şahin, İkbal Ok Bozkaya, Namık Yaşar Özbek
Hematol Transfus Cell Ther. 2021;43 Supl 3:S62
Open access
A CASE OF POLYCYTHEMIA DIAGNOSED AS HEMOGLOBIN ANDREW-MINNEAPOLIS
Mustafa Bilici, Serap Karaman, Aysegul Unuvar, Deniz Tugcu, Gülsah Tanyildiz, Ayca Dilruba Aslanger, Oya Uyguner, Rumeysa Tuna Deveci, ... Zeynep Karakas
Hematol Transfus Cell Ther. 2021;43 Supl 3:S62-S63
Open access
THE SMALLEST PRIMARY BONE LYMPHOMA
Fatma Burçin KURTİPEK, Volkan KÖSE, Seda ŞAHİN, Derya ÖZYÖRÜK, Neriman SARI, Sonay İNCESOY ÖZDEMİR, Arzu YAZAL ERDEM, Meriç KAYMAK, İnci İLHAN ERGÜRHAN
Hematol Transfus Cell Ther. 2021;43 Supl 3:S63
Open access
MRI FINDINGS OF BONE MARROW AT THE BEGINNING OF LEUKEMIA
Seda Şahin, Neriman Sarı, Tülin Demirkan
Hematol Transfus Cell Ther. 2021;43 Supl 3:S63
Open access
THREE CASES WITH BURKITT LYMPHOMA PRESENTING WITH CHOLESTASIS
Fatma Tuba YILDIRIM, Derya ÖZYÖRÜK, Arzu YAZAL ERDEM, Selma ÇAKMAKCI, Neriman SARI, Sonay İNCESOY, İnci İLHAN
Hematol Transfus Cell Ther. 2021;43 Supl 3:S63
Open access
HIGH GRADE GLIOMA OF CENTRAL NERVOUS SYSTEM: SINGLE CENTER TREATMENT EXPERIENCE
Nur OLGUN, Deniz KIZMAZOGLU, Batuhan OZDOGAR, Dilek INCE, Emre CECEN, Ceren KIZMAZOGLU, Şefika AKYOL, Ayşe DEMIRAL, ... Erdener OZER
Hematol Transfus Cell Ther. 2021;43 Supl 3:S63-S64
Open access
ONC 201 PRACTICE IN DIFFUSE MIDLINE GLIOMA (H3K27M MUTANT)
Bahattin Tanrıkulu, Cengiz Canpolat, Ahmet Harun Yaşar, Ayça Erşen Danyeli, M. Memet Özek
Hematol Transfus Cell Ther. 2021;43 Supl 3:S64
Open access
PARATESTICULAR INVOLVEMENT IN NEUROBLASTOMA
Volkan KÖSE, Sabri DEMİR, Neriman SARI
Hematol Transfus Cell Ther. 2021;43 Supl 3:S64
Open access
PRIMARY EWING'S SARCOMA OF SPHENOID BONE EXTENDING TO BRAINSTEM; AN ORDINARY TUMOUR AT AN EXTRAORDINARY LOCATION AND INVOLVEMENT
Seda ŞAHİN, İnci İlhan
Hematol Transfus Cell Ther. 2021;43 Supl 3:S64-S65
Open access
ACTINOMYCES ODONTOLYTICUS: A RARE CAUSE OF PEDIATRIC FEBRILE NEUTROPENIA
Meric KAYMAK CIHAN, Sonay INCESOY OZDEMIR, Belgin GULHAN, Arzu YAZAL ERDEM, Derya OZYORUK, Neriman SARI, Inci ERGURHAN ILHAN
Hematol Transfus Cell Ther. 2021;43 Supl 3:S65
Open access
WITHDRAWN: THE EFFECT OF NIVOLUMAB IN PEDIATRIC MALIGNANT TUMORS: A SINGLE CENTER EXPERIENCE WITH EIGHT PATIENTS
Veysel GOK, Firdevs AYDIN, Alper OZCAN, Ebru YILMAZ, Ekrem UNAL, Musa KARAKUKCU, Türkan PATIROGLU, Mehmet Akif OZDEMIR, ... Atil BISGIN
Hematol Transfus Cell Ther. 2021;43 Supl 3:S65
Open access
A CASE DIAGNOSED WITH FOUR DIFFERENT TUMORS
Fatma Tuba YILDIRIM, Derya ÖZYÖRÜK, Arzu YAZAL ERDEM, Selma ÇAKMAKCI, Neriman SARI, Sonay İNCESOY, İnci İLHAN
Hematol Transfus Cell Ther. 2021;43 Supl 3:S65
Open access
Speaker presentations
CURRENT THERAPY FOR INDOLENT LYMPHOMAS
Guilherme Duffles, Marcia Torresan Delamain, Carmino Antonio De Souza
Hematol Transfus Cell Ther. 2021;43 Supl 3:S66-S67
Open access
ELN recommendations for treating MDS
David Bowen
Hematol Transfus Cell Ther. 2021;43 Supl 3:S67
Open access
How I treat Polycythemia vera
Barbara Mora, Frencesco Passamonti
Hematol Transfus Cell Ther. 2021;43 Supl 3:S67-S68
Open access
Haematological emergencies and the early warning score tool for nurses
Dana Parness
Hematol Transfus Cell Ther. 2021;43 Supl 3:S69
Open access
How to COVID pandemic changed clinical practice
Medine Yılmaz
Hematol Transfus Cell Ther. 2021;43 Supl 3:S69
Open access
Congenital neutropenias: Türkish Registry
Deniz Yılmaz Karapınar
Hematol Transfus Cell Ther. 2021;43 Supl 3:S69-S70
Open access
Hereditary macrothrombocyte disorders
Zühre Kaya
Hematol Transfus Cell Ther. 2021;43 Supl 3:S70-S71
Open access
Treatment of sickle cell in 2021
Salam Alkindi
Hematol Transfus Cell Ther. 2021;43 Supl 3:S71
Open access
Special content about COVID-19
Publish in
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.